Central nervous system (CNS) involvement with diffuse large B‐cell lymphoma (DLBCL) is a
relatively uncommon manifestation; with most cases of CNS involvement occuring during …

BACKGROUND The number of elderly patients with diffuse large B‐cell lymphoma (DLBCL)
in our aging society continues to rise, although the optimal management of very elderly …

Background Diffuse large B-cell lymphoma (DLBCL) is characterized by its clinical and
biological heterogeneity. The clinical prognostic implications of tumor-associated …

Secondary central nervous system (CNS) progression in patients with non-Hodgkin
lymphoma (NHL) is associated with a particularly poor prognosis. In this review, we …

Neoadjuvant radio-chemotherapy followed by total mesorectal excision (TME) is the
standard treatment option for stage II and III rectal cancer. However, for pT3N0 rectal cancer …

The absolute peripheral blood lymphocyte count at diagnosis is known to be a strong
prognostic factor in patients with diffuse large B-cell lymphoma (DLBCL) treated with …

The objective of this study was to investigate the prognostic value of peripheral blood
monocytes in esophageal squamous cell carcinoma (ESCC) patients who underwent …

Absolute count of circulating monocytes has been proposed as an independent prognostic
factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes …

Aims To propectively reveal the clinicopathological and prognostic significances of
monocyte-lymphocyte ratio (MLR), neutrophil-lymphocyte ratio (NLR) and platelet …

Objective Primary adrenal lymphoma (PAL) is easily misdiagnosed as other adrenal
masses, such as adrenocortical carcinoma and pheochromocytoma, but patients with PAL …